NVS Stock Price, Chart, Stats & News

Novartis AG
Save
NVS chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 75.73% |
Operating margin | 31.25% |
Pretax margin | 29.12% |
Net margin | 24.90% |
Effective tax rate | 14.59% |
ROA | 12.10% |
ROE | 32.75% |
D/E | 0.80x |
Interest coverage ratio | 15.28x |
NVS valuation
P/E | 20.58x |
P/S | 5.10x |
P/B | 6.14x |
P/CF | 14.82x |
P/FCF | 18.31x |
P/OCF | 14.82x |
PEG | -9.32x |
EV multiple | 11.43x |
About
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers.
Similar securities
Based on sector and market capitalization
Report issue











